#MedRxiv

Anke Hüls

anke_huels

In March 2020 we formed the @t21rs COVID-19 Initiative to understand the impact of COVID-19 in individuals with Down syndrome. Huge team effort that has resulted in data of >1,000

Dr. Ali Nouri

AliNouriPhD

1) It's not uncommon to recover from COVID, test negative, and then test positive again down the line. Happened to ~1 out of 5 recovered patients in large China study

Buzz Hollander MD

buzzhollandermd

Our first real world data on vaccine effectiveness in the US is here, complements of the Mayo Clinic.Spoiler alert: it is good!It's not a randomized trial, of course;and the cohort

Hilda Bastian, PhD

hildabast

Preprint of the South African phase 1b/2 trial for the Oxford/AstraZeneca vaccine is online. Primary efficacy analysis is for 2,026 people who weren't infected with HIV (there was also a

Victor Chernozhukov

VC31415

Came across this paper that does panel regressions of Y (Covid growth rates) ~ P (adopted polices) + fixed effects. The elementary modeling mistake is not to control for

Monica Gandhi MD, MPH

MonicaGandhi9

I know I am all over the place today but my 2 favorite COVID-19 topics are masking & immunity. Today good day for masking & here is another study (super

Peter Higgins

ibddoctor

THREAD: More data about PPIs and SARS-CoV-2 coming out. Is there a consistent association across studies? @statsepi @DrToddLee @supermarioelia @mikejohansenmd @ADAlthousePhD Increased prevalence of ARDS in those taking PPI at

Amit Thadhani

amitsurg

Just read the pre-print paper. This is looking very good indeed, best of all vaccine candidates so far. Short thread follows.https://twitter.com/ETHealthWorld/status/1339412593123856384 Covaxin is a killed vaccine. Two doses 14 days

seth masters

sethmasters

An autoinflammatory syndrome caused by DPP9 deficiency, leading to NLRP1 inflammasome activation! Wonderful collaboration with Zhong lab and @ReversadeLab, led by @CassHarapas @KimSamirah and Kenneth Lay, with Jon Bernstein and

David Wees

davidwees

This fascinating app lets one determine the exposure time in various settings (assuming those settings include at least one infected individual) with a given risk tolerance. https://indoor-covid-safety.herokuapp.com/ It is based

Sargon Maradkel

TheRealMaradkel

To whom it SHOULD concern, To whom whose heart SHOULD ache, it has been exactly…138 DAYS since Dr. John Ioannidis @METRICStanfordconducted a study proving people

Ben CatchYourCough Goldacre

bengoldacre

I assumed that posting a PDF to a preprint server means sharing it under open licenses for general re-use, CC-BY or similar? I guess this email from PMC (pestering me

Josh - Data Analyst in Nashville

ifihadastick

Christmas Eve update : % Positive Curves by NOAA CLIMATE Region State Groups:Perhaps instead of attributing a pandemic to your gov's policies, consider other phenomena at playI hope it frees

Eric Feigl-Ding

DrEricDing

HYDROXYCHLOROQUINE - Recovery trial results finally out - and hopefully puts nail in coffin. Out of 4700 people randomized... HCQ did NOT lower #covid19 mortality. It anything it was trending

el gato malo

boriquagato

this is an important issue to internalize:so much defense and resistance to COV-19 is based in t-cells, that sero-prevalence of antibodies can be a very misleading figure.in this german study,

Michael Mina

michaelmina_lab

Here, we evaluated the economic return on investment of this plan had we started in June - Dec 2020. The version described above is shown in panel CCosts (all included)

By continuing to use the site, you are consenting to the use of cookies as explained in our Cookie Policy to improve your experience.